Authors: KNECHTLI CJC GOULDEN NJ HANCOCK JP HARRIS EL GARLAND RJ JONES CG GRANDAGE VLG ROWBOTTOM AW GREEN AF CLARKE E LANKESTER AW POTTER MN CORNISH JM PAMPHILON DH STEWARD CG OAKHILL A

Citation: Cjc. Knechtli et al., MINIMAL RESIDUAL DISEASE STATUS AS A PREDICTOR OF RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, British Journal of Haematology, 102(3), 1998, pp. 860-871

Authors: KNECHTLI CJC GOULDEN NJ HANCOCK JP GRANDAGE VLG HARRIS EL GARLAND RJ JONES CG ROWBOTTOM AW HUNT LP GREEN AF CLARKE E LANKESTER AW CORNISH JM PAMPHILON DH STEWARD CG OAKHILL A

Citation: Cjc. Knechtli et al., MINIMAL RESIDUAL DISEASE STATUS BEFORE ALLOGENEIC BONE-MARROW TRANSPLANTATION IS AN IMPORTANT DETERMINANT OF SUCCESSFUL OUTCOME FOR CHILDREN AND ADOLESCENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 92(11), 1998, pp. 4072-4079

Authors: BOURA ALA GREEN AF

Citation: Ala. Boura et Af. Green, THE ACTIONS OF BRETYLIUM - ADRENERGIC-NEURON BLOCKING AND OTHER EFFECTS (REPRINTED FROM BRIT J PHARMACOL, VOL 14, PG 536, 1959), British Journal of Pharmacology, 120(4), 1997, pp. 166-178